Passive Transdermal Drug Delivery Market Report

China Passive Transdermal Drug Delivery Industry Market Research Report 2023-2029

  • POSTDATE：Oct 14, 2023
  • PAGES：187
  • REPORT CODE：GMM1855665
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Passive Transdermal Drug Delivery industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Noven Pharmaceuticals, Inc

    • Actavis, Inc

    • Corium International, Inc

    • Novartis AG

    • Mylan NV

    • Johnson & Johnson (Janssen Pharmaceuticals Inc)

    • Echo Therapeutics, Inc

    • 3M

    • GlaxoSmithKline plc

    • Bayer AG

    By Type:

    • Smart Pill Technology (SPT)

    • Microfluidics

    By Application:

    • Clinic

    • Hospital

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Passive Transdermal Drug Delivery Market Overview 2018-2029

    • 1.1 China Passive Transdermal Drug Delivery Industry Development Overview

    • 1.2 China Passive Transdermal Drug Delivery Industry Development History

    • 1.3 China Passive Transdermal Drug Delivery Industry Market Size (2018-2029)

    • 1.4 China Passive Transdermal Drug Delivery Market Analysis by Type from Production Side

      • 1.4.1 China Passive Transdermal Drug Delivery Production Volume, Production Value and Growth Rate of Smart Pill Technology (SPT) (2018-2029)

      • 1.4.2 China Passive Transdermal Drug Delivery Production Volume, Production Value and Growth Rate of Microfluidics (2018-2029)

    • 1.5 China Passive Transdermal Drug Delivery Market Analysis by Application from Consumption End

      • 1.5.1 China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Passive Transdermal Drug Delivery Market Analysis by Region

      • 1.6.1 North China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    Chapter 2 China Passive Transdermal Drug Delivery Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Passive Transdermal Drug Delivery Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Passive Transdermal Drug Delivery Market Status and Competition Analysis in 2023

      • 2.2.3 China Passive Transdermal Drug Delivery Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Passive Transdermal Drug Delivery Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Passive Transdermal Drug Delivery Industry Development

    Chapter 3 Passive Transdermal Drug DeliveryIndustry Chain Analysis

    • 3.1 Passive Transdermal Drug Delivery Industry Chain

    • 3.2 Passive Transdermal Drug Delivery Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Passive Transdermal Drug Delivery Market

    • 3.3 Passive Transdermal Drug Delivery Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Passive Transdermal Drug Delivery Market

    Chapter 4 China Passive Transdermal Drug Delivery Market, by Type

    • 4.1 China Passive Transdermal Drug Delivery Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Passive Transdermal Drug Delivery Total Production Volume and Growth Rate from Production Side

    • 4.5 China Passive Transdermal Drug Delivery Production Volume and Growth Rate, by Type

      • 4.5.1 China Passive Transdermal Drug Delivery Production Volume and Growth Rate of Smart Pill Technology (SPT)

      • 4.5.2 China Passive Transdermal Drug Delivery Production Volume and Growth Rate of Microfluidics

    Chapter 5 China Passive Transdermal Drug Delivery Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Passive Transdermal Drug Delivery Total Market Size and Growth Rate from Consumption End

    • 5.5 China Passive Transdermal Drug Delivery Market Size and Growth Rate, by Application

      • 5.5.1 China Passive Transdermal Drug Delivery Market Size and Growth Rate of Clinic

      • 5.5.2 China Passive Transdermal Drug Delivery Market Size and Growth Rate of Hospital

      • 5.5.3 China Passive Transdermal Drug Delivery Market Size and Growth Rate of Others

    Chapter 6 China Passive Transdermal Drug Delivery Market, by Region

    • 6.1 China Passive Transdermal Drug Delivery Production Volume and Production Value, by Region

    • 6.2 China Passive Transdermal Drug Delivery Sales Volume and Sales Value, by Region

    Chapter 7 North China Passive Transdermal Drug Delivery Market Analysis

    • 7.1 North China Passive Transdermal Drug Delivery Market, by Type

    • 7.2 North China Passive Transdermal Drug Delivery Market, by Application

    Chapter 8 Central China Passive Transdermal Drug Delivery Market Analysis

    • 8.1 Central China Passive Transdermal Drug Delivery Market, by Type

    • 8.2 Central China Passive Transdermal Drug Delivery Market, by Application

    Chapter 9 South China Passive Transdermal Drug Delivery Market Analysis

    • 9.1 South China Passive Transdermal Drug Delivery Market, by Type

    • 9.2 South China Passive Transdermal Drug Delivery Market, by Application

    Chapter 10 East China Passive Transdermal Drug Delivery Market Analysis

    • 10.1 East China Passive Transdermal Drug Delivery Market, by Type

    • 10.2 East China Passive Transdermal Drug Delivery Market, by Application

    Chapter 11 Northeast China Passive Transdermal Drug Delivery Market Analysis

    • 11.1 Northeast China Passive Transdermal Drug Delivery Market, by Type

    • 11.2 Northeast China Passive Transdermal Drug Delivery Market, by Application

    Chapter 12 Southwest China Passive Transdermal Drug Delivery Market Analysis

    • 12.1 Southwest China Passive Transdermal Drug Delivery Market, by Type

    • 12.2 Southwest China Passive Transdermal Drug Delivery Market, by Application

    Chapter 13 Northwest China Passive Transdermal Drug Delivery Market Analysis

    • 13.1 Northwest China Passive Transdermal Drug Delivery Market, by Type

    • 13.2 Northwest China Passive Transdermal Drug Delivery Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Noven Pharmaceuticals, Inc

        • 14.1.1 Noven Pharmaceuticals, Inc Company Profile

        • 14.1.2 Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Actavis, Inc

        • 14.2.1 Actavis, Inc Company Profile

        • 14.2.2 Actavis, Inc Passive Transdermal Drug Delivery Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Corium International, Inc

        • 14.3.1 Corium International, Inc Company Profile

        • 14.3.2 Corium International, Inc Passive Transdermal Drug Delivery Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis AG

        • 14.4.1 Novartis AG Company Profile

        • 14.4.2 Novartis AG Passive Transdermal Drug Delivery Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Mylan NV

        • 14.5.1 Mylan NV Company Profile

        • 14.5.2 Mylan NV Passive Transdermal Drug Delivery Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Johnson & Johnson (Janssen Pharmaceuticals Inc)

        • 14.6.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Profile

        • 14.6.2 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Echo Therapeutics, Inc

        • 14.7.1 Echo Therapeutics, Inc Company Profile

        • 14.7.2 Echo Therapeutics, Inc Passive Transdermal Drug Delivery Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 3M

        • 14.8.1 3M Company Profile

        • 14.8.2 3M Passive Transdermal Drug Delivery Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GlaxoSmithKline plc

        • 14.9.1 GlaxoSmithKline plc Company Profile

        • 14.9.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Bayer AG

        • 14.10.1 Bayer AG Company Profile

        • 14.10.2 Bayer AG Passive Transdermal Drug Delivery Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Passive Transdermal Drug Delivery Industry Research Conclusions

    • 15.2 Passive Transdermal Drug Delivery Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Passive Transdermal Drug Delivery Industry Market Size (2018-2029)

    • Figure China Passive Transdermal Drug Delivery Production Volume, Production Value and Growth Rate of Smart Pill Technology (SPT) (2018-2029)

    • Figure China Passive Transdermal Drug Delivery Production Volume, Production Value and Growth Rate of Microfluidics (2018-2029)

    • Figure China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Central China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure South China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure East China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Passive Transdermal Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Passive Transdermal Drug Delivery Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Passive Transdermal Drug Delivery Market Share by Type in 2018

    • Figure China Passive Transdermal Drug Delivery Market Share by Type in 2023

    • Figure China Passive Transdermal Drug Delivery Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Production Volume and Growth Rate of Smart Pill Technology (SPT) (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Production Volume and Growth Rate of Microfluidics (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Market Share by Application in 2018

    • Figure China Passive Transdermal Drug Delivery Market Share by Application in 2023

    • Figure China Passive Transdermal Drug Delivery Total Market Size and Growth Rate from Consumption End

    • Figure China Passive Transdermal Drug Delivery Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Market Size and Growth Rate of Others (2018-2023)

    • Table China Passive Transdermal Drug Delivery Production Volume by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Production Volume Share by Region (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Production Volume Share by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Production Value by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Production Value Share by Region (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Production Value Share by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Sales Volume by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Sales Volume Share by Region (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Sales Volume Share by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Sales Value by Region (2018-2023)

    • Table China Passive Transdermal Drug Delivery Sales Value Share by Region (2018-2023)

    • Figure China Passive Transdermal Drug Delivery Sales Value Share by Region (2018-2023)

    • Table North China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table North China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure North China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table North China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table North China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure North China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Central China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table Central China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Central China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Central China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table Central China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Central China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table South China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table South China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure South China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table South China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table South China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure South China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table East China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table East China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure East China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table East China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table East China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure East China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Northeast China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table Northeast China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Northeast China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Northeast China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table Northeast China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Southwest China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table Southwest China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Southwest China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Southwest China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table Southwest China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Northwest China Passive Transdermal Drug Delivery Production Volume by Type (2018-2023)

    • Table Northwest China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Northwest China Passive Transdermal Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Northwest China Passive Transdermal Drug Delivery Sales Volume by Application (2018-2023)

    • Table Northwest China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Passive Transdermal Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Noven Pharmaceuticals, Inc Company Profile

    • Table Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Actavis, Inc Company Profile

    • Table Actavis, Inc Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Corium International, Inc Company Profile

    • Table Corium International, Inc Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Mylan NV Company Profile

    • Table Mylan NV Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Profile

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Echo Therapeutics, Inc Company Profile

    • Table Echo Therapeutics, Inc Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table 3M Company Profile

    • Table 3M Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Passive Transdermal Drug Delivery Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US